*/
A practical guide by defence and prosecution
Deferred prosecution agreements (DPAs), a relatively recent addition to the UK criminal justice toolkit, allow a company which has committed a criminal offence to avoid prosecution if it complies with a range of conditions, including a hefty financial penalty.
The specialist panel, moderated by Stuart Alford QC, offered a crash course in practical language that even tired brains could understand.
Sir Edward Garnier QC MP described DPAs as an idea born from austerity. Prosecuting complex crime is expensive and time-consuming, so he looked to the US’s experience in dealing with corporate wrongdoing. The provisions in the Crime and Courts Act 2013 resemble the US model, but there is one principal difference: the UK model involves active judicial supervision of the agreement. This element was essential for the legislation to obtain political, judicial and public support.
Ben Morgan gave an insight into what the Serious Fraud Office (SFO) is looking for when considering a DPA. In short, a company should approach the SFO early, investigate wrongdoing fully and openly and be as forthcoming as possible about the facts. Winning does not mean defeating your opponent; it means securing court approval for a DPA. Ultimately, the court can only approve a DPA if it is in the interests of justice and the terms are fair, reasonable and proportionate. This balance can be very difficult to achieve. On the one hand, there must be a punishment for wrongdoing. On the other hand, it is in the interest of employees, pensioners and suppliers for the company to remain a going concern, and there must be some incentive for the company to self-report.
Alison Levitt QC argued that the need for early self-reporting poses a challenge for companies. Once a company has self-reported, there is no going back. In practice, companies are likely to begin with their own investigation, followed by a risk assessment of whether the wrongdoing will ever be discovered. They will also be mindful of the risk of prosecution in other countries; although the SFO can work with its counterparts in other countries to avoid duplicate proceedings, there are no binding treaties so there remains a risk of international prosecution. Her advice was to investigate potential wrongdoing early and comprehensively, using external lawyers. As soon as there is a reasonable suspicion of criminal acts, the company cannot procrastinate. If a DPA is sought, companies must prepare to negotiate a sufficient discount on the financial penalty to make the risk worth taking.
The session left me with a good basic knowledge of DPAs and an idea of where to look if I need to know more. What more could I ask in an hour?
Contributor Aoife Drudy
The specialist panel, moderated by Stuart Alford QC, offered a crash course in practical language that even tired brains could understand.
Sir Edward Garnier QC MP described DPAs as an idea born from austerity. Prosecuting complex crime is expensive and time-consuming, so he looked to the US’s experience in dealing with corporate wrongdoing. The provisions in the Crime and Courts Act 2013 resemble the US model, but there is one principal difference: the UK model involves active judicial supervision of the agreement. This element was essential for the legislation to obtain political, judicial and public support.
Ben Morgan gave an insight into what the Serious Fraud Office (SFO) is looking for when considering a DPA. In short, a company should approach the SFO early, investigate wrongdoing fully and openly and be as forthcoming as possible about the facts. Winning does not mean defeating your opponent; it means securing court approval for a DPA. Ultimately, the court can only approve a DPA if it is in the interests of justice and the terms are fair, reasonable and proportionate. This balance can be very difficult to achieve. On the one hand, there must be a punishment for wrongdoing. On the other hand, it is in the interest of employees, pensioners and suppliers for the company to remain a going concern, and there must be some incentive for the company to self-report.
Alison Levitt QC argued that the need for early self-reporting poses a challenge for companies. Once a company has self-reported, there is no going back. In practice, companies are likely to begin with their own investigation, followed by a risk assessment of whether the wrongdoing will ever be discovered. They will also be mindful of the risk of prosecution in other countries; although the SFO can work with its counterparts in other countries to avoid duplicate proceedings, there are no binding treaties so there remains a risk of international prosecution. Her advice was to investigate potential wrongdoing early and comprehensively, using external lawyers. As soon as there is a reasonable suspicion of criminal acts, the company cannot procrastinate. If a DPA is sought, companies must prepare to negotiate a sufficient discount on the financial penalty to make the risk worth taking.
The session left me with a good basic knowledge of DPAs and an idea of where to look if I need to know more. What more could I ask in an hour?
Contributor Aoife Drudy
A practical guide by defence and prosecution
Deferred prosecution agreements (DPAs), a relatively recent addition to the UK criminal justice toolkit, allow a company which has committed a criminal offence to avoid prosecution if it complies with a range of conditions, including a hefty financial penalty.
The Chair of the Bar reports back
Clement Cowley, Partner at The Penny Group, explains how global events can influence the performance of pensions and ISAs, and why taking a long-term approach to investing is often the most effective strategy
Mário Barroso, Head of R&D and Method Development at AlphaBiolabs, discusses what family law professionals need to know about hallucinogens, from the main hallucinogenic drugs encountered in family proceedings, to their effects and the testing options available
Harmony Christian Ministries is the latest charity to benefit from a £500 donation from AlphaBiolabs via the company’s Giving Back initiative
By David Green
Mário Barroso, Head of R&D and Method Development at AlphaBiolabs, examines the forensic science underpinning hair drug testing, its evidential scope and limitations, and why it remains the gold standard for evidencing patterns of drug use in family proceedings
Developing a tech start-up demands a different definition of excellence to the Bar, says Saara Idelbi. The co-creator of Advocatr on entrepreneurship, AI advocacy training, and matching the thrill of a killer cross-examination
At the start of her term, Chair of the Bar 2026 Kirsty Brimelow KC set out a series of priorities for the year ahead. One of those priorities was children in the justice system
As the world becomes more digital, Barbara Vinagre Mota examines international research into the mental health consequences of judges’ exposure to graphic and immersive evidence, highlighting the importance of support systems
Reviewed by Daniel Barnett
James McNeill Whistler at Tate Britain until 27 September Rothko in Florence at Palazzo Strozzi until 23 August Reviewed by Stephen Cragg KC